search
Back to results

Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI) (FLUID)

Primary Purpose

Brain Injuries

Status
Unknown status
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
Sterofundin
0.9% saline
Sponsored by
University of Malaya
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Brain Injuries focused on measuring Traumatic brain injury, isotonic balanced fluid

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients age between 18 and 65 years of age
  • Non-penetrating moderate (GCS 9-12) or severe (GCS 3-8) traumatic brain injury
  • Within 12 hours since the recorded time of injury

Exclusion Criteria:

  • Pregnancy
  • Polytrauma
  • Cardiac arrest at presentation
  • GCS of three with bilateral fixed dilated pupils,
  • Evidence of severe cardiac, respiratory, renal or liver dysfunction

Sites / Locations

  • University of Malaya Medical Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Strerofundin

0.9% saline

Arm Description

Days of intervention: 3 days

Days of intervention: 3 days

Outcomes

Primary Outcome Measures

30 day mortality
Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E)

Secondary Outcome Measures

Acid-base balance
through out intervention period
Daily mean change in intracranial pressure (ICP)
through out intervention period
Episodes of intracranial hypertension
through out intervention period
Duration of mechanical ventilation
through out intervention period
Length of ICU stay
through out intervention period
electrolyte balance
ICU mortality

Full Information

First Posted
May 23, 2016
Last Updated
October 25, 2016
Sponsor
University of Malaya
search

1. Study Identification

Unique Protocol Identification Number
NCT02866604
Brief Title
Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)
Acronym
FLUID
Official Title
Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Unknown status
Study Start Date
October 2016 (undefined)
Primary Completion Date
August 2018 (Anticipated)
Study Completion Date
February 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Malaya

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The main objective of this study is to compare the clinical outcomes of TBI patients receiving only Sterofundin or 0.9% saline as main fluid therapy.
Detailed Description
Study Design: Prospective single centre double-blind randomized controlled trial Study endpoints/outcomes Primary outcomes: 30 day mortality Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E) Secondary outcomes: Acid-base and electrolyte balance Daily mean change in intracranial pressure (ICP) Episodes of intracranial hypertension Duration of mechanical ventilation Length of ICU stay and ICU mortality Study Duration: 2 years Site: UMMC. Departments involved: Emergency Medicine, Surgery, Anaesthesiology and Pharmacy Methodology. Investigators will assess patients admitted to the Emergency Department, UMMC, for eligibility. Randomisation: Investigators will randomize patients in a 1:1 ratio to either 0.9% saline intravenous fluid group or Sterofundin® intravenous fluid group. An independent statistician not involved with the research will perform a block of eight randomisation using computerised number generator list. Conduct of study The Department of Pharmacy will identically seal all 0.9% saline and Sterofundin® intravenous fluid bottles and label them, according to their type, as either A or B. The patients, investigators and medical and nursing staff will not be aware of the designation of the letters A and B to the fluids. Investigators will administer the study fluid will immediately after patient randomisation and this will last for 72 hours. Other general care of the traumatic brain injury patients from both study arms will continue as per Neurosurgical Unit protocol and Brain Trauma Foundation guidelines. Data handling Investigators will collect all data relevant to both primary and secondary outcomes (see also attached proforma): Statistical analysis Investigators will conduct students t test, Chi squared and the Mann-Whitney U test as appropriate. Investigators will adjust results with univariable and multivariable logistic regression and report their odds ratio. Investigators will present survival analysis using Kaplan Meier curves and compare them using log rank test.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Injuries
Keywords
Traumatic brain injury, isotonic balanced fluid

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Strerofundin
Arm Type
Active Comparator
Arm Description
Days of intervention: 3 days
Arm Title
0.9% saline
Arm Type
Active Comparator
Arm Description
Days of intervention: 3 days
Intervention Type
Procedure
Intervention Name(s)
Sterofundin
Intervention Type
Procedure
Intervention Name(s)
0.9% saline
Primary Outcome Measure Information:
Title
30 day mortality
Time Frame
30 days
Title
Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E)
Time Frame
180 days
Secondary Outcome Measure Information:
Title
Acid-base balance
Description
through out intervention period
Time Frame
3 days
Title
Daily mean change in intracranial pressure (ICP)
Description
through out intervention period
Time Frame
3 days
Title
Episodes of intracranial hypertension
Description
through out intervention period
Time Frame
3 days
Title
Duration of mechanical ventilation
Description
through out intervention period
Time Frame
3 days
Title
Length of ICU stay
Description
through out intervention period
Time Frame
30 days
Title
electrolyte balance
Time Frame
3 days
Title
ICU mortality
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients age between 18 and 65 years of age Non-penetrating moderate (GCS 9-12) or severe (GCS 3-8) traumatic brain injury Within 12 hours since the recorded time of injury Exclusion Criteria: Pregnancy Polytrauma Cardiac arrest at presentation GCS of three with bilateral fixed dilated pupils, Evidence of severe cardiac, respiratory, renal or liver dysfunction
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sia S Fu, MSurg, PhD
Phone
+603-79492441
Email
sfsia02@um.edu.my
Facility Information:
Facility Name
University of Malaya Medical Centre
City
Petaling Jaya
State/Province
Wilayah Persekutuan Kuala Lumpur
ZIP/Postal Code
50603
Country
Malaysia
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sia S Fung, MSurg, PhD
Phone
+603-79492441
Email
sfsia02@um.edu.my

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)

We'll reach out to this number within 24 hrs